Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition.

Background: Dietary supplements (DS) are widely used to address nutritional deficiencies and promote health, yet their indiscriminate use often leads to reduced efficacy, adverse effects, and safety concerns. Biomarker-driven approaches have emerged as a promising strategy to optimize DS prescriptio...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 16; no. 23; pp. 4033 - 4049
Autores principales: Pokushalov, Evgeny, Ponomarenko, Andrey, Shrainer, Evgenya, Kudlay, Dmitry, Miller, Richard
Formato: review Journal Article
Publicado: MDPI Dec2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181658697&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 181658697
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: Dec2024
      vid: 16
      iid: 23
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        181658697
        181658697
        181658697
        10.3390/nu16234033
        181658697
      ppf: 4033
      ppct: 16
      formats:
      tig:
        atl: Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition.
      aug:
        au:
          Pokushalov, Evgeny
          Ponomarenko, Andrey
          Shrainer, Evgenya
          Kudlay, Dmitry
          Miller, Richard
        affil: Center for New Medical Technologies, Novosibirsk 630090, Russia
      sug:
        subj:
          Biological Markers Analysis
          Dietary Supplementation Evaluation
          Individualized Medicine
          Nutrition
          Artificial Intelligence Utilization
          Disease Prevention and Control
          Health Promotion
          Genomics
          Proteomics
          Metabolomics
          Microbiota
          Oxidoreductases
          Blood Glucose
          Insulin Blood
          Metabolic Diseases
          Needs Assessment
      ab: Background: Dietary supplements (DS) are widely used to address nutritional deficiencies and promote health, yet their indiscriminate use often leads to reduced efficacy, adverse effects, and safety concerns. Biomarker-driven approaches have emerged as a promising strategy to optimize DS prescriptions, ensuring precision and reducing risks associated with generic recommendations. Methods: This narrative review synthesizes findings from key studies on biomarker-guided dietary supplementation and the integration of artificial intelligence (AI) in biomarker analysis. Key biomarker categories—genomic, proteomic, metabolomic, lipidomic, microbiome, and immunological—were reviewed, alongside AI applications for interpreting these biomarkers and tailoring supplement prescriptions. Results: Biomarkers enable the identification of deficiencies, metabolic imbalances, and disease predispositions, supporting targeted and safe DS use. For example, genomic markers like MTHFR polymorphisms inform folate supplementation needs, while metabolomic markers such as glucose and insulin levels guide interventions in metabolic disorders. AI-driven tools streamline biomarker interpretation, optimize supplement selection, and enhance therapeutic outcomes by accounting for complex biomarker interactions and individual needs. Limitations: Despite these advancements, AI tools face significant challenges, including reliance on incomplete training datasets and a limited number of clinically validated algorithms. Additionally, most current research focuses on clinical populations, limiting generalizability to healthier populations. Long-term studies remain scarce, raising questions about the sustained efficacy and safety of biomarker-guided supplementation. Regulatory ambiguity further complicates the classification of supplements, especially when combinations exhibit pharmaceutical-like effects. Conclusions: Biomarker-guided DS prescription, augmented by AI, represents a cornerstone of personalized nutrition. While offering significant potential for precision and efficacy, advancing these strategies requires addressing challenges such as incomplete AI data, regulatory uncertainties, and the lack of long-term studies. By overcoming these obstacles, clinicians can better meet individual health needs, prevent diseases, and integrate precision nutrition into routine care.
      pubtype: Academic Journal
      doctype:
        review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N